Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced CancerMizuki Nishino, F. Stephen Hodi|JAMA Oncology|2016Cited by 750
Lung Volumes and Emphysema in Smokers with Interstitial Lung AbnormalitiesGeorge R. Washko, Iván O. Rosas, Gary M. Hunninghake et al.|New England Journal of Medicine|2011Cited by 615
Association Between Interstitial Lung Abnormalities and All-Cause MortalityRachel K. Putman, Hiroto Hatabu, Tetsuro Araki et al.|JAMA|2016Cited by 468
<i>MUC5B</i> Promoter Polymorphism and Interstitial Lung AbnormalitiesGary M. Hunninghake, David A. Schwartz, Hiroto Hatabu et al.|New England Journal of Medicine|2013Cited by 450
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M. Sholl, Laura E. MacConaill, T. Khanh et al.|JCI Insight|2016Cited by 447